Clinigen (Clinigen Group) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines to improve the quality of people's lives around the world.

We are the global leading experts, trusted by both pharmaceutical and biotech companies and healthcare professionals, in providing access to medicines throughout the lifecycle of a medicine; clinical trials, unlicensed and commercial supply.

Clinigen’s mission is to deliver the right medicine to the right patient at the right time operating in three areas of global medicine supply: clinical trials, unlicensed and licensed medicines.

Operating in a complex regulatory environment, Clinigen is the only company to globally manage access to medicine across all three routes worldwide. We understand the complex challenges facing Pharmaceutical and Biotech companies and are uniquely placed to provide the solutions to help.

Clinigen add insight, expertise and value at every stage of a product’s lifecycle, supporting pharmaceutical companies and healthcare professionals from clinical trials, unlicensed supply and full commercialisation of medicines. That is why, for over 30 years, Clinigen has been trusted by industry and healthcare providers to enable access to more innovative medicines, in more countries, for more patients than anyone else.